{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001937993","name":"Cadrenal Therapeutics, Inc.","summary":"Cadrenal Therapeutics is a late-stage biopharmaceutical company developing novel therapies for life-threatening immune and thrombotic conditions. Its lead candidate, CAD-1005, is a first-in-class selective 12-LOX inhibitor for heparin-induced thrombocytopenia (HIT), with Phase 1 and Phase 2 data and an End-of-Phase 2 FDA meeting completed. Its pipeline also includes tecarfarin, an oral vitamin K antagonist for chronic anticoagulation, and frunexian, an IV Factor XIa inhibitor for acute care settings.","people":[],"products":[{"name":"CAD-1005","type":"platform","description":"First-in-class selective 12-LOX inhibitor in clinical development for heparin-induced thrombocytopenia (HIT), with FDA Orphan Drug and Fast Track designations."},{"name":"Tecarfarin","type":"platform","description":"Oral vitamin K antagonist designed as a warfarin replacement for patients with kidney dysfunction or left ventricular assist devices requiring chronic anticoagulation."},{"name":"Frunexian","type":"platform","description":"First-in-class Phase 2-ready IV Factor XIa inhibitor targeting acute/critical care hospital settings where contact activation of coagulation by medical devices is significant."},{"name":"CAD-2000 series","type":"platform","description":"Back-up and follow-on compounds to CAD-1005, including parenteral and oral second-generation 12-LOX inhibitor candidates for acute and chronic conditions."}],"partnerships":[{"partner_name":"Old Dominion University (successor to Eastern Virginia Medical School)","partnership_type":"licensing","description":"Exclusive worldwide license under EVMS Patent Rights for development and commercialization of 12-Lipoxygenase Inhibitors, assigned to Cadrenal via Veralox asset purchase.","start_date":null},{"partner_name":"Veralox Therapeutics Inc.","partnership_type":"acquisition","description":"Asset purchase of CAD-1005 (formerly VLX-1005) and related 12-LOX platform assets, including IP, inventory, contracts, and regulatory designations.","start_date":null}],"affiliations":[],"origin":{"leaf":"f703e94ef174c682d4df1be47ae545cc2cb8be486571d0c7438417fbd143ca30","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"839d1e5f7c1ec94a492a33680a707f639ec21e1fbf8cf6046e1d5825ffac3b47","parent":"402364ca886eef67b793a54c465f9912b3030a3ed46835dd76dfbc04dd655d62","source":"0001213900-26-036946","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":177,"hourly_limit":500,"remaining":323,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}